The SAVI Group's private equity strategy addresses the leverage problem at its source rather than managing its consequences.
Growth equity deployment replaces the leveraged buyout structure. Capital infusions enable strategic expansion, workforce investment, and market development without loading the portfolio company with debt obligations that constrain operating decisions and reduce the available responses to any future pressure to cost reduction and accelerated exit. This is not a moderate version of the conventional model. It is a structurally different approach that produces structurally different outcomes.
Target selection reflects that difference. Approximately 60 percent of evaluated targets are eliminated at the early review stage on governance compatibility grounds before financial analysis proceeds. The screening criteria ask whether the target's governance culture can support the 50/50 distribution model, whether leadership will encode executive compensation discipline in governance documents, and whether the institutional culture can sustain the transparency that the model's reporting architecture requires.
Return architecture targets a preferred investor return of 1.5x equity multiple and 25 percent IRR before GP catch-up activates, with the full distribution waterfall mechanics described on The SAVI Capital Model page. These parameters reflect the model's structural design and are not representations of guaranteed or historical performance. Fund-specific terms are available through the formal institutional due diligence process for qualified reviewers.
Performance Disclaimer: All performance references on this page reflect industry-level analytical benchmarks and research-derived estimates from third-party institutional sources cited in The SAVI Capital Model due diligence materials. They do not represent audited fund performance or historical returns of any fund managed by The SAVI Group, are not specific to any fund managed by the firm, and do not constitute a guarantee or representation of future results.